June 15, 2021

Digital Therapeutics Market Size, Share, Industry Analysis and Regional Forecast 2020-2027

Digital Therapeutics Market

The increasing prevalence of chronic diseases is expected to fuel demand for digital therapeutics during the forecast period, states Fortune Business Insights, in a report, titled “Digital Therapeutics Market Size, Share & Industry Analysis, By Application (Diabetes, Weight Management, Cardiovascular Diseases, Respiratory Diseases, Others), By Product (Software, Devices), By End-user (Patients, Caregivers) and Regional Forecast 2020-2027.” The market size is likely to proliferate owing to the growing geriatric population.

The occurrence of coronavirus has caused enormous damage to various businesses across the world. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.

We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/digital-therapeutics-market-103501

The report on the digital therapeutics market reveals:

Renowned insights into the industry
Important data with in-depth research
Factors exhibiting market growth
Wide-ranging study about main regions
COVID-19 impact on the market
Prime developments in the industry
Market Driver:

Surging Cases of Cardiovascular Diseases to Bolster Growth

The increasing cases of heart strokes can improve the prospects of the market in the forthcoming years. As per the data reported by the American Heart Association’s Heart and Stroke Statistics – 2019, nearly half of (48%, 121.5 million in 2016) of all adults in the United States suffered from some type of cardiovascular disease. The growing emphasis on early diagnosis, disease prevention, and patient convenience can spur lucrative opportunities for the market. Moreover, the increasing prevalence of chronic diseases owing to lack of physical exercise, sedentary lifestyles, and increased consumption of junk food can favor the market growth in the forthcoming years. The surging healthcare development and growing technological advancements are expected to contribute positively to the market’s growth.

Digital therapeutic delivers authentic therapeutic interventions to patients and offers high-quality software programs to inhibit, accomplish, or treat a medical disease or disorder.

However, lack of awareness and hesitancy among patients to adopt digital therapeutics are factors expected to hamper the market’s growth. Besides, data privacy concerns are expected to further hinder the market’s growth in the forthcoming years.

Click here to request a sample copy of the Research Report

Regional Analysis:
Favorable Government Initiatives to Push Growth in North America
North America is expected to hold the largest share globally due to the increasing prevalence of chronic diseases. The favorable government initiatives in the U.S. are expected to contribute positively to the region’s market growth. The refining compensation structure for digital therapeutic solutions and accumulative investment in the digital therapeutics field is expected to boost North America’s development. Asia Pacific is expected to expand radically during the forecast period owing to the increasing prevalence of chronic illness. Moreover, the growing geriatric population and expansion of digital therapeutics can further uplift the region’s market.

The Major Companies in The Global Digital TherapeuticsInclude:

Proteus Digital Health Inc.
Omada Health Inc.
Welldoc Inc.
Livongo Health
Noom Inc.
Propeller Health
Mango Health Inc.
2Morrow, Inc.
Notable Development:
November 2019: Welldoc and Astellas Pharma Inc. developed and commercialized the Bluestar product in Japan and Asia.
October 2019: 2Morrow launched the first digital health smartphone app to help teens and young adults quit vaping.

June 2019: Catasys Inc. announced a partnership with CANARY HEALTH to aid more significant portion of the population through digital therapeutics.

Enquire before buying: https://www.fortunebusinessinsights.com/enquiry/queries/digital-therapeutics-market-103501

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]